Evidence map›Paper›PMID 28597077›Full record

ArticleVirchows Archiv : an international journal of pathology2017

Is Rosai-Dorfman disease a reactve process? Detection of a MAP2K1 L115V mutation in a case of Rosai-Dorfman disease.

Matthias S Matter, Michel Bihl, Darius Juskevicius, Alexandar Tzankov

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Orbital histiocytosis; From A to Z.International ophthalmology · 2024
    Review
  5. Review
  6. Rosai-Dorfman disease of the cauda equina: illustrative case.Journal of neurosurgery. Case lessons · 2024
    Article
  7. Review
  8. Article
  9. Extranodal Rosai-Dorfman Disease- a Review of Diagnostic Testing and Management.Journal of community hospital internal medicine perspectives · 2022
    Article
  10. Article
  11. Rosai-Dorfman disease.Pathologica · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Blood advances · 2019
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matthias S MatterInstitute of Pathology, University of Basel, Schönbeinstrasse 40, 4003, Basel, Switzerland.
Michel BihlInstitute of Pathology, University of Basel, Schönbeinstrasse 40, 4003, Basel, Switzerland.
Darius JuskeviciusInstitute of Pathology, University of Basel, Schönbeinstrasse 40, 4003, Basel, Switzerland.
Alexandar TzankovInstitute of Pathology, University of Basel, Schönbeinstrasse 40, 4003, Basel, Switzerland. alexandar.tzankov@usb.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedHistiocytosis, SinusHumansMaleMAP Kinase Kinase 1Mutation, MissenseMAP2K1 protein, humanMAP Kinase Kinase 1

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.